$96.74
▼ -0.0% Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 1
● 24
▼ 0
CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue?
Is CVS Health Outperforming the Nasdaq?
CVS Health Reports Availability of Updated COVID-19 Vaccines
Overview
52-week range
$70
$111
66% of range
Avg surprise (last 3)
+23.7%
Avg reaction (last 2)
+5.9%
100% positive
Latest IV / EM
29%
EM ±1.2% · $97 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $2.31 | — | — | — | — | financials |
| Wed May 6, 2026 | Mar/2026 | $2.57 | $2.21 | +16.3% | +14.2% | +7.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-3.13 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $1.81 | $1.47 | +23.1% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $2.25 | $1.71 | +31.6% | — | +4.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.07 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $1.41 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.88 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $1.75 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $1.48 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $1.65 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $106.10B | $100.43B | — | $102.87B | $98.92B | $94.59B | — | $95.43B |
| Cost of revenue | $58.86B | $55.44B | — | $57.05B | $54.01B | $51.06B | — | $52.95B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $4.70B | $4.68B | — | $-3.21B | $2.38B | $3.37B | — | $832M |
| Net income | $2.98B | $2.96B | — | $-3.98B | $1.02B | $1.78B | — | $87M |
| EPS (diluted) | $2.31 | $2.30 | — | $-3.13 | $0.80 | $1.41 | — | $0.07 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $11.33B | $9.54B | $8.45B | $9.10B | $11.79B | $10.08B | $8.59B | $6.88B |
| Inventory | $17.62B | $17.77B | $19.25B | $18.96B | $17.45B | $17.39B | $18.11B | $17.65B |
| Total current assets | $75.35B | $74.82B | $74.71B | $77.11B | $75.65B | $73.19B | $68.64B | $67.34B |
| Total assets | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $173.87B | $175.34B | $178.16B | $182.22B | $180.79B | $178.47B | $177.49B | $177.32B |
| Total equity | $79.70B | $77.64B | $75.21B | $72.93B | $77.55B | $77.11B | $75.56B | $75.11B |